INTERIM RESULTS OF A PHASE 2 STUDY OF XMAB®5871, A REVERSIBLE B CELL INHIBITOR, IN IGG4-RELATED DISEASE

被引：3
|
作者：
Stone, J. H. [1 ]
Wallace, Z. S. [1 ]
Perugino, C. A. [1 ]
Fernandes, A. D. [1 ]
Patel, P. S. [1 ]
Foster, P. A. [2 ]
Zack, D. J. [2 ]
机构：
[1] Harvard, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA USA
[2] Xencor Inc, Clin Dev, Monrovia, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0588
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [21] Obexelimab in IgG4-related disease: B-cell inhibition as a novel therapeutic approach
    Alexander, Tobias
    Burmester, Gerd R.
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (08): : E428 - E429
  • [22] Biliary Obstruction Caused by B-Cell Lymphoma Associated With IgG4-Related Disease
    Ogawa, Kazuya
    Sato, Hiroki
    Ikarashi, Satoshi
    Hayashi, Kazunao
    Terai, Shuji
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (11): : 2166 - 2166
  • [23] B cell depletion after treatment with rituximab predicts relapse of IgG4-related disease
    Lanzillotta, Marco
    Ramirez, Giuseppe Alvise
    Milani, Raffaella
    Dagna, Lorenzo
    Della-Torre, Emanuel
    [J]. RHEUMATOLOGY, 2024,
  • [24] B-cell depletion works in IgG4-related disease. What else?
    Della-Torre, Emanuel
    Dagna, Lorenzo
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 127 : 39 - 40
  • [25] Roles of Regulatory T and B Cells in IgG4-Related Disease
    Uchida, Kazushige
    Okazaki, Kazuichi
    [J]. IGG4-RELATED DISEASE, 2017, 401 : 93 - 114
  • [26] A PHASE 1B/2A STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF XMAB®5871 IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Jaraczewska-Baumann, M.
    Korkosz, M.
    Sulyok, G.
    Sramek, P.
    Rojkovich, B.
    Daniluk, S.
    Bartalos, J.
    Zack, D. J.
    Foster, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 481 - 481
  • [27] Concurrent IgG4-Related disease and clear cell renal cell carcinoma
    Chow, Kar Ven Cavan
    Hossain, Shahadat
    [J]. UROLOGY CASE REPORTS, 2022, 40
  • [28] Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients
    Zeng, Qiaozhu
    Gao, Jingyuan
    Zhang, Xinyu
    Liu, Aichun
    Wang, Zhenfan
    Wang, Ziqiao
    Chi, Xiying
    Shi, Qianyu
    Wang, Yi
    Yang, Fei
    Liu, Yanying
    Li, Zhan-Guo
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] IGG4-RELATED DISEASE: RESULTS FROM ARGENTINEAN SOCIETY OF RHEUMATOLOGY REGISTRY
    Ortiz, A.
    Scolnik, M.
    Gandino, I.
    Caeiro, F.
    Baenas, D.
    Aste, N.
    Catoggio, C.
    Pisoni, C.
    Duartes Noe, D.
    Bartel, G.
    Gallo, J.
    Juarez, V.
    Crespo, M.
    Paira, S.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S144 - S144
  • [30] IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease
    Geyer, Julia T.
    Niesvizky, Ruben
    Jayabalan, David S.
    Mathew, Susan
    Subramaniyam, Shivakumar
    Geyer, Alexander I.
    Orazi, Attilio
    Ely, Scott A.
    [J]. MODERN PATHOLOGY, 2014, 27 (03) : 375 - 381
12345